Recurrent Kikuchi-Fujimoto Disease Successfully Treated by the Concomitant Use of Hydroxychloroquine and Corticosteroids

  • Honda Fumika
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Tsuboi Hiroto
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Toko Hirofumi
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Ohyama Ayako
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Takahashi Hidenori
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Abe Saori
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Yokosawa Masahiro
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Asashima Hiromitsu
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Hagiwara Shinya
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Hirota Tomoya
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Kondo Yuya
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Matsumoto Isao
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan
  • Sumida Takayuki
    Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Japan

この論文をさがす

説明

<p>Kikuchi-Fujimoto disease (KFD) is a benign disease of unknown etiology characterized by lymphadenopathy and a fever. For the majority of patients with KFD, the course is self-limited; however, the optimum method of managing recurrent cases has not yet been established. We herein report a case of a 42-year-old Japanese woman with KFD (confirmed by a lymph node biopsy). Although high-dose prednisolone (PSL) rapidly induced remission, she experienced four recurrences on treatment tapering. Concomitant use of hydroxychloroquine (HCQ) with low-dose PSL induced continuous remission. This is the first case to suggest the effectiveness of HCQ for recurrent KFD in a Japanese patient. </p>

収録刊行物

  • Internal Medicine

    Internal Medicine 56 (24), 3373-3377, 2017

    一般社団法人 日本内科学会

参考文献 (12)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ